Details for New Drug Application (NDA): 213803
✉ Email this page to a colleague
The generic ingredient in SUNITINIB MALATE is sunitinib malate. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sunitinib malate profile page.
Summary for 213803
Tradename: | SUNITINIB MALATE |
Applicant: | Teva Pharms Usa |
Ingredient: | sunitinib malate |
Patents: | 0 |
Pharmacology for NDA: 213803
Mechanism of Action | Protein Kinase Inhibitors |
Suppliers and Packaging for NDA: 213803
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 213803 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-8199 | 0093-8199-28 | 28 CAPSULE in 1 BOTTLE (0093-8199-28) |
SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 213803 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-8224 | 0093-8224-28 | 28 CAPSULE in 1 BOTTLE (0093-8224-28) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 12.5MG BASE | ||||
Approval Date: | Nov 30, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Nov 30, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 37.5MG BASE | ||||
Approval Date: | Nov 30, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription